IR News
2026
2026/03/27 Voting Results of the 41st General Shareholders' Meeting
Detail 2026/03/26 Resolutions of the 41st General Meeting of Shareholders
Detail 2026/03/26 Notice Regarding Disposal of Treasury Stock as Restricted Stock Compensation
Detail 2026/03/25 FY2025 Annual Securities Report (English Excerpt Translation of the Yukashoken-Hokokusho For the 41st Fiscal Year from January 1, 2025 to December 31, 2025)
Detail 2026/03/10 (Correction) Notice Concerning Partial Correction of Consolidated Financial Results for the Fiscal Year Ended December 31, 2025(Under Japanese GAAP)
Detail 2026/03/04 Notice of the 41st General Meeting of Shareholders
Detail 2026/02/25 Full-text transcript of the financial results briefing for FY2025 (Japanease Only) 2026/02/12 Announcement Regarding the Establishment of "Growth Strategy and Shareholder Return Policy 2026-2030"
Detail 2026/02/12 Presentation Material for FY2025 Business Results
Detail 2026/02/12 FY2025 Consolidated Financial Results (Japanese GAAP)
Detail 2026/01/28 Notice Regarding Appointment of New Directors
Detail 2026/01/28 Notice Concerning Revision of Dividend Forecast (Dividend Increase)
Detail 2026/01/20 Notice of Preliminary Results on Product Implementations
Detail 2025
2025/11/27 Announcement Regarding Results and Completion of Repurchase of Own Shares
Detail 2025/11/13 Supplementary Information on FY2025 3rd Quarter Business Results Summary
Detail 2025/11/13 FY2025 Q3 Consolidated Financial Results (Japanese GAAP)
Detail 2025/11/05 Announcement regarding progress of the share repurchases
Detail 2025/11/04 Notice Concerning the Passing and Resignation of Corporate Officer
Detail 2025/10/29 Notice Regarding the Establishment of the "Medical Data Platform Business"
Detail 2025/10/01 Announcement regarding progress of the share repurchases
Detail 2025/09/01 Announcement regarding progress of the share repurchases
Detail 2025/08/21 Full-text transcript of the financial results briefing for Q2 FY2025 (Japanease Only) 2025/08/13 Presentation Material for Q2 FY2025 Business Results
Detail 2025/08/13 FY2025 Q2 Consolidated Financial Results (Japanese GAAP)
Detail 2025/08/01 Announcement regarding progress of the share repurchases
Detail 2025/08/01 Corporate Information Updated
Detail 2025/07/16 Notice of Preliminary Results on Product Implementations
Detail 2025/07/14 Notice Regarding Launch of Free Plan for Medical Document Creation Service
Detail 2025/07/01 Announcement regarding progress of the share repurchases
Detail 2025/06/02 Announcement regarding progress of the share repurchases
Detail 2025/05/14 Supplementary Information on FY2025 1st Quarter Business Results Summary
Detail 2025/05/14 FY2025 Q1 Consolidated Financial Results (Japanese GAAP)
Detail 2025/05/01 Announcement regarding progress of the share repurchases
Detail 2025/04/14 Notice Regarding Completion of Payment for Disposal of Treasury Stock as Restricted Stock Compensation
Detail 2025/04/01 Announcement regarding progress of the share repurchases
Detail 2025/04/01 Notice of Changes in Organizational Structure and Appointments of Officers
Detail 2025/03/28 Voting Results of the 40th General Shareholders' Meeting
Detail 2025/03/28 FY2024 Annual Securities Report (English Excerpt Translation of the Yukashoken-Hokokusho For the 40th Fiscal Year from January 1, 2024 to December 31, 2024)
Detail 2025/03/28 Resolutions of the 40th General Meeting of Shareholders
Detail 2025/03/27 Notice Regarding Disposal of Treasury Stock as Restricted Stock Compensation
Detail 2025/03/10 Notice of Resolution on Share Repurchase
Detail 2025/03/05 Notice of the 40th General Meeting of Shareholders
Detail 2025/02/25 Full-text transcript of the financial results briefing for FY2024 (Japanease Only) 2025/02/13 Presentation Material for FY2024 Business Results
Detail 2025/02/13 FY2024 Consolidated Financial Results (Japanese GAAP)
Detail 2025/01/20 Notice Regarding the Contracted Operations for the Platform of Electronic Prescriptions and Electronic Dispensing Registrations
Detail 2025/01/16 Notice of Preliminary Results on Product Implementations
Detail 2024
2024/11/13 Supplementary Information on FY2024 3rd Quarter Business Results Summary
Detail 2024/11/13 FY2024 Q3 Consolidated Financial Results (Japanese GAAP)
Detail 2024/08/20 Full-text transcript of the financial results briefing for Q2 FY2024 (Japanease Only) 2024/08/13 Presentation Material for Q2 FY2024 Business Results
Detail 2024/08/13 FY2024 Q2 Consolidated Financial Results (Japanese GAAP)
Detail 2024/07/26 Notice Regarding the Revision of the Financial Forecast for the Second Quarter of the Fiscal Year Ending December 31, 2024
Detail 2024/07/18 Notice of Preliminary Results on Product Implementations
Detail 2024/05/14 Supplementary Information on FY2024 1st Quarter Business Results Summary
Detail 2024/05/14 FY2024 Q1 Consolidated Financial Results (Japanese GAAP)
Detail 2024/04/12 Notice Regarding Completion of Payment for Disposal of Treasury Stock as Restricted Stock Compensation
Detail 2024/03/28 Resolutions of the 39th General Meeting of Shareholders
Detail 2024/03/28 Voting Results of the 39th General Shareholders' Meeting
Detail 2024/03/28 FY2023 Annual Securities Report (English Excerpt Translation of the Yukashoken-Hokokusho For the 39th Fiscal Year from January 1, 2023 to December 31, 2023)
Detail 2024/03/27 Notice Regarding Disposal of Treasury Stock as Restricted Stock Compensation
Detail 2024/03/05 Notice of the 39th General Meeting of Shareholders
Detail 2024/02/22 Notice of Meeting the Continued Listing Criteria of the Prime Market Segment
Detail 2024/02/21 Full-text transcript of the financial results briefing for FY2023 (Japanease Only) 2024/02/13 Presentation Material for FY2023 Business Results
Detail 2024/02/13 Notice Regarding Dividend of Surplus (Dividend Increase)
Detail 2024/02/13 FY2023 Consolidated Financial Results (Japanese GAAP)
Detail 2024/01/17 Notice of Preliminary Results on Product Implementations
Detail 2023
2023/11/13 Supplementary Information on Q3 FY2023 Financial Results Summary
Detail 2023/11/13 FY2023 Q3 Consolidated Financial Results (Japanese GAAP)
Detail 2023/08/24 Full-text transcript of the financial results briefing for Q2 FY2023 (External link) 2023/08/09 Presentation Material for Q2 FY2023 Business Results
Detail 2023/08/09 FY2023 Q2 Consolidated Financial Results (Japanese GAAP)
Detail 2023/07/19 Notice of Preliminary Results on Product Implementations
Detail 2023/05/11 Corporate profile is updated
Detail 2023/05/11 Supplementary Information on FY2023 1st Quarter Business Results Summary
Detail 2023/05/11 FY2023 Q1 Consolidated Financial Results (Japanese GAAP)
Detail 2023/05/11 Notice Regarding Completion of Payment for Disposal of Treasury Stock as Restricted Stock Compensation
Detail 2023/04/14 Notice Regarding Disposal of Treasury Stock as Restricted Stock Compensation
Detail 2023/04/03 Notice of Changes in Organizational Structure and Assignments of Officers
Detail 2023/03/29 Voting Results of the 38th General Shareholders' Meeting
Detail 2023/03/29 FY2022 Annual Securities Report (English Excerpt Translation of the Yukashoken-Hokokusho For the 38th Fiscal Year from January 1, 2022 to December 31, 2022)
Detail 2023/03/29 Resolutions of the 38th General Meeting of Shareholders
Detail 2023/03/24 Plan to Comply with the Continued Listing Criteria of the Prime Market
Detail 2023/03/09 Notice of the 38th General Meeting of Shareholders
Detail 2023/02/24 Findex starts publishing the full-text transcript of the financial results briefing 2023/02/22 Fiscal Year 2022 Consolidated Financial Results Briefing
Detail 2023/02/20 (Amendment) Notice of Completion of the Revision of Medium-Term Business Plan
Detail 2023/02/20 Presentation video is now available 2023/02/17 Corporate profile is updated
Detail 2023/02/13 Notice of Introduction of a Restricted Stock Compensation Plan
Detail 2023/02/13 Notice of Completion of the Revision of Medium-Term Business Plan
Detail 2023/02/13 FY2022 Consolidated Financial Results (Japanese GAAP)
Detail 2023/01/19 Notice of Preliminary Results on Product Implementations
Detail 2023/01/16 Notice of Establishment of New Departments
Detail 2023/01/16 Notice of Change in Reporting Business Segments
Detail 2022
2022/12/26 Notice of Revision of Medium Term Business Plan
Detail 2022/11/10 FY2022 Q3 Consolidated Financial Results (Japanese GAAP)
Detail 2022/08/26 Fiscal Year 2022 Second Quarter Consolidated Financial Results Briefing
Detail 2022/08/26 Presentation video is now available 2022/08/26 Corporate profile is updated
Detail 2022/08/09 [Correction] Notice of partial corrections to the Consolidated Financial Results [Japanese GAAP]
Detail 2022/06/24 Notice of Change in a Consolidated Subsidiary
Detail 2022/05/18 Notice Regarding the Revision of the Financial Forecast for the Second Quarter of the Fiscal Year Ending December 31, 2022 (Consolidated, Non-consolidated)
Detail 2022/05/06 Strategic Alliance with Toyota Tsusho Corporation
Detail 2018
2018/03/05 Notice on Business Allainace Basic Agreement reached with Canon Medical Systems Corp
Detail 2017
2017/02/03 Notice on Establishment of Consolidated Subsidiary
Detail 2016
2016/11/11 Notification of a Revision to the Performance Forecast
Detail 2016/08/08 Notice of Acquisition of Treasury Stock
Detail 2016/07/26 Notification of a Revision to the Performance Forecast
Detail